Evidence map›Paper›PMID 36135189›Full record

ArticleCurrent issues in molecular biology2022

Toxicity, Safety, and Efficacy Studies on Mesenchymal Stem Cells Derived from

Priya Subramani, Jaianand Kannaiyan, Saurabh Khare, Paulraj Balaji, Atif Abdulwahab A Oyouni, Saad Ali S Aljohani, Mishal Olayan Alsulami, Osama M Al-Amer, Othman R Alzahrani, Malik A Altayar and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current issues in molecular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Priya SubramaniPG and Research Centre in Microbiology, MGR College, Hosur 635109, India.
Jaianand KannaiyanResearch and Development, CellCure Therapeutics, Coimbatore 641046, India.
Saurabh KhareResearch and Development, Dr. Scientific Solutions, Gurgaon 122003, India.
Paulraj BalajiPG and Research Centre in Biotechnology, MGR College, Hosur 635109, India.ORCID 0000-0002-6839-4785
Atif Abdulwahab A OyouniDepartment of Biology, Faculty of Sciences, University of Tabuk, Tabuk 71491, Saudi Arabia.ORCID 0000-0001-8762-4999
Saad Ali S AljohaniDepartment of Clinical Pharmacy, Faculty of Health Sciences and Nursing, Alrayan Colleges, Almadinah 42541, Saudi Arabia.
Mishal Olayan AlsulamiCytogenetic and Molecular Genetics, Clinical Laboratory Department, Prince Sultan Medical City, Riyadh 11159, Saudi Arabia.ORCID 0000-0001-6218-7868
Osama M Al-AmerGenome and Biotechnology Unit, Faculty of Sciences, University of Tabuk, Tabuk 71491, Saudi Arabia.
Othman R AlzahraniDepartment of Biology, Faculty of Sciences, University of Tabuk, Tabuk 71491, Saudi Arabia.ORCID 0000-0002-2726-0473
Malik A AltayarDepartment of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk 71491, Saudi Arabia.ORCID 0000-0002-3394-0686
Afrah Awadh Allah AlsulamiMinistry of Environment, Water, and Agriculture, Riyadh 11195, Saudi Arabia.
Veeramanikandan VeeramaniPG and Research Centre in Microbiology, MGR College, Hosur 635109, India.ORCID 0000-0002-6235-1223

Funding

Researchers Supporting Project, CellCure Therapeutics CCT-2020/42
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

decidua basalislethal dosemaximal tolerance dosemesenchymal stem cellsminimal lethal dose

Identifiers

PMID36135189
PMCPMC9498010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.